Koers BrightGene Bio-Medical Technology Co., Ltd.
Aandelen
688166
CNE100003PR1
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
36,8 CNY | +5,66% | +3,84% | +5,14% |
Omzet 2022 | 1,02 mld. 141 mln. 130 mln. | Omzet 2023 | 1,18 mld. 163 mln. 150 mln. | Marktkapitalisatie | 14,79 mld. 2,05 mld. 1,88 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 240 mln. 33,23 mln. 30,57 mln. | Nettowinst (verlies) 2023 | 202 mln. 27,97 mln. 25,73 mln. | EV/omzet 2022 | 10,2 x |
Nettoschuld 2022 | 791 mln. 110 mln. 101 mln. | Nettoschuld 2023 | 1,16 mld. 160 mln. 148 mln. | EV/omzet 2023 | 13,5 x |
K/w-verhouding 2022 |
38,9
x | K/w-verhouding 2023 |
72,9
x | Werknemers | 1.155 |
Dividendrendement 2022 |
0,51% | Dividendrendement 2023 |
0,27% | Vrij verhandelbaar | 48,25% |
1 dag | +5,66% | ||
1 week | +3,84% | ||
Lopende maand | +18,75% | ||
1 maand | +41,38% | ||
3 maanden | +49,23% | ||
6 maanden | +8,55% | ||
Lopend jaar | +5,14% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jian Dong Yuan
CEO | Chief Executive Officer | 54 | 26-10-01 |
Yuan Lai Zou
DFI | Director of Finance/CFO | 53 | 01-01-11 |
Fan Hang
BRD | Director/Board Member | 38 | 01-01-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jian Dong Yuan
CEO | Chief Executive Officer | 54 | 26-10-01 |
Kai Li
PRN | Corporate Officer/Principal | 48 | 01-01-07 |
Ying Xian Shen
BRD | Director/Board Member | 38 | 18-09-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +3,87% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-05-24 | 36,8 | +5,66% | 13 277 160 |
16-05-24 | 34,83 | +1,02% | 10 512 340 |
15-05-24 | 34,48 | -0,12% | 6 443 476 |
14-05-24 | 34,52 | -1,00% | 6 766 584 |
13-05-24 | 34,87 | -1,61% | 8 937 755 |
slotkoers Shanghai S.E., 17 mei 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,14% | 2,15 mld. | |
+32,09% | 693 mld. | |
+29,39% | 584 mld. | |
-1,34% | 372 mld. | |
+20,34% | 332 mld. | |
+7,39% | 294 mld. | |
+14,25% | 239 mld. | |
-3,03% | 211 mld. | |
+10,02% | 210 mld. | |
+8,49% | 168 mld. |